Literature DB >> 12720542

Progesterone effects during sequential hormone replacement therapy.

Lotta Andréen1, Mari Bixo, Sigrid Nyberg, Inger Sundström-Poromaa, Torbjörn Bäckström.   

Abstract

OBJECTIVE: The aim was to investigate the effect on mood and the physical symptoms of two dosages of natural progesterone and a placebo in postmenopausal women with and without a history of premenstrual syndrome (PMS).
DESIGN: A randomized, placebo-controlled, double-blind, crossover study was performed.
METHOD: Postmenopausal women (n=36) with climacteric symptoms were recruited. They received 2 mg estradiol continuously during three 28-day cycles. Vaginal progesterone suppositories with 800 mg/day, 400 mg/day, or placebo were added sequentially for 14 days per cycle. Daily symptom ratings using a validated rating scale were kept.
RESULTS: Women without a history of PMS showed cyclicity in both negative mood and physical symptoms while on 400 mg/day progesterone but not on the higher dose or the placebo. Women without a history of PMS had more physical symptoms on progesterone treatment compared with placebo. Women with prior PMS reported no progesterone-induced symptom cyclicity.
CONCLUSION: In women without prior PMS natural progesterone caused negative mood effects similar to those induced by synthetic progestogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12720542     DOI: 10.1530/eje.0.1480571

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  Postmenopausal hormone use impact on emotion processing circuitry.

Authors:  Tal Shafir; Tiffany Love; Alison Berent-Spillson; Carol C Persad; Heng Wang; Nancy K Reame; Kirk A Frey; Jon-Kar Zubieta; Yolanda R Smith
Journal:  Behav Brain Res       Date:  2011-09-14       Impact factor: 3.332

Review 2.  Neuroimaging the Menstrual Cycle and Premenstrual Dysphoric Disorder.

Authors:  Erika Comasco; Inger Sundström-Poromaa
Journal:  Curr Psychiatry Rep       Date:  2015-10       Impact factor: 5.285

3.  Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone.

Authors:  Lotta Andréen; Inger Sundström-Poromaa; Marie Bixo; Sigrid Nyberg; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

Review 4.  Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.

Authors:  Anna-Carin N-Wihlbäck; Inger Sundström-Poromaa; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

5.  A prospective study of hormone therapy and depression in community-dwelling elderly women: the Three City Study.

Authors:  Jacqueline Scali; Joanne Ryan; Isabelle Carrière; Jean-François Dartigues; Béatrice Tavernier; Karen Ritchie; Marie-Laure Ancelin
Journal:  J Clin Psychiatry       Date:  2010-08-10       Impact factor: 4.384

Review 6.  Progesterone, reproduction, and psychiatric illness.

Authors:  Lindsay R Standeven; Katherine O McEvoy; Lauren M Osborne
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-06-18       Impact factor: 5.237

Review 7.  The role of hormones and hormonal treatments in premenstrual syndrome.

Authors:  Torbjörn Bäckström; Lotta Andreen; Vita Birzniece; Inger Björn; Inga-Maj Johansson; Maud Nordenstam-Haghjo; Sigrid Nyberg; Inger Sundström-Poromaa; Göran Wahlström; Mingde Wang; Di Zhu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Effects of acute progesterone administration upon responses to acute psychosocial stress in men.

Authors:  Emma Childs; Nicholas T Van Dam; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2010-02       Impact factor: 3.157

9.  Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy.

Authors:  Maria Pia Rogines-Velo; Amy E Heberle; Hadine Joffe
Journal:  Menopause       Date:  2012-04       Impact factor: 2.953

10.  The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.

Authors:  Allison Kimball; Laura E Dichtel; Maren B Nyer; David Mischoulon; Lauren B Fisher; Cristina Cusin; Christina M Dording; Nhi-Ha Trinh; Albert Yeung; Melanie S Haines; Joshua C Sung; Graziano Pinna; Ann M Rasmusson; Linda L Carpenter; Maurizio Fava; Anne Klibanski; Karen Klahr Miller
Journal:  Psychoneuroendocrinology       Date:  2019-11-14       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.